Phenotypic and Molecular Epidemiology of Acinetobacter calcoaceticus baumannii Complex Strains Spread at Nemazee Hospital of Shiraz, Iran

Jundishapur Journal of Microbiology
Mojtaba AnvarinejadAfsaneh Vazin

Abstract

Acinetobacter calcoaceticus baumannii (ACB) complex are Gram-negative opportunistic bacteria with low virulence properties. Their resistance to antibiotics has become a matter of concern in hospital infections. The present study aimed to determine the prevalence and antimicrobial susceptibility of ACB isolates collected from the Nemazee hospital of Shiraz. In addition, Pulsed Field Gel Electrophoresis (PFGE) was used to determine the genetic patterns of these strains. In this cross-sectional study, 93 strains of ACB complex were isolated from patients of Nemazee hospital, Shiraz, Iran. The antibiotic susceptibility patterns of the isolates to the following 15 antibiotics were determined: gentamicin, ticarcillin, ceftazidime, co-trimoxazole, imipenem, piperacillin tazobactam, amikacin, aztreonam, sulbactam, meropenem, tobramycin, cefotaxime, ceftriaxone, colistin, polymyxin B. Pulsed Field Gel Electrophoresis was used to determine the clonal relationship of these strains. Most of the isolates were found to be resistant to cefotaxime, co-trimoxazole, ceftriaxone, aztreonam, ceftazidime and ticarcillin (90%), and the least resistance was observed to colistin and polymyxin B. Among the 93 tested samples, 35 antimicrobial susceptibi...Continue Reading

References

May 10, 2005·Journal of Community Health Nursing·Joan EngebretsonGlenda Walker
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Mar 21, 2007·Emerging Infectious Diseases·Rebecca H SunenshineArjun Srinivasan
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Oct 22, 2008·Journal of Bacteriology·Mark D AdamsSteven R Gill
Sep 16, 2009·Emerging Infectious Diseases·Young Kyoung ParkKwan Soo Ko
May 28, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joel Fishbain, Anton Y Peleg
Jul 9, 2010·BMC Infectious Diseases·Lemuel L DentRobert B Hulette
Aug 27, 2010·Journal of Clinical Microbiology·Naomi RunnegarDavid L Paterson
Oct 5, 2010·Journal of Bacteriology·María A MussiLuis A Actis
Dec 24, 2010·Journal of Clinical Microbiology·Pilar VillalónJuan A Saez-Nieto
Jan 15, 2011·Clinical Microbiology Reviews·Emily R M Sydnor, Trish M Perl
May 11, 2011·Bulletin of the World Health Organization·Emily LeungUNKNOWN World Health Organization World Health Day Antimicrobial Resistance Technical Working Group
Sep 10, 2011·Journal of Medical Microbiology·Ali Rezaei-MatehkolaeiHossein Mirhendi
Dec 14, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Kai-Chih ChangMing-Li Liou
Sep 14, 2012·Journal of Clinical Microbiology·Radosław IzdebskiMarek Gniadkowski
Dec 25, 2012·Journal of Medical Microbiology·Agnes SonnevendTibor Pál
Dec 26, 2012·Diagnostic Microbiology and Infectious Disease·Roberta MigliavaccaFrancesco Luzzaro
Jun 19, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Abbas BahadorReza Raoofian
Jun 1, 2010·The HIM Journal·Linda Best

❮ Previous
Next ❯

Citations

Jan 14, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hadi Razavi NikooJalal Mardaneh

❮ Previous
Next ❯

Methods Mentioned

BETA
Electrophoresis

Software Mentioned

Numerical Taxonomy System ( NTSYS ) pc
PhotoCapt

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
S López-HernándezM López-Brea
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
M I García-ArataM López-Brea
Journal of the Indian Medical Association
Ajay Vir SinghArchana Thakur
© 2021 Meta ULC. All rights reserved